Using a novel mouse model that allows scientists to study how the immune system's fighter cells respond to invaders in the genital tract during the initial stage of infection, Harvard Medical School (HMS) researchers have found a way to track immunity against Chlamydia trachomatis. The new findings could help hasten the development of vaccines for Chlamydia – the most common cause of bacterial sexually transmitted disease (STD) in the United States – and other STDs. The study appears in the July 24 early edition online of the Proceedings of the National Academy of Sciences.
"Right now Chlamydia is sensitive to treatment with antibiotics, but the problem is that many people have 'silent' infections that remain untreated," said researcher Michael Starnbach, PhD, HMS associate professor of microbiology and molecular genetics. "These undiagnosed infections over time lead to complications like tubal pregnancy and infertility. The goal would be to vaccinate young people to keep them from suffering from undiagnosed infection and the bad outcomes associated with it."
Most pathogens (disease-causing bacteria or viruses) enter a host by penetrating mucosal surfaces such as the lung, intestine, or genito-urinary tract. The prevalence of sexually transmitted diseases has prompted studies to understand how infection is established in the genital tract and how pathogens are cleared from this site. Before Starnbach's study, however, it had not been possible to monitor invader-specific T cell (fighter cell) responses to initial infection in reproductive tissue, despite the recognized importance of T cells in controlling a number of genital pathogens
"Humans and mice have an enormous variety of T cells that are prepared to respond to pathogens – even pathogens to which they have never been exposed," Starnbach said. "Yet prior to infection, the number of T cells specific for any single pathogen is extremely low. The number is so low that it is impossible to track and monitor the activity of these T cells during their first encounter with the microbe."
To circumvent the problem, Starnbach and colleagues in the HMS Department of Microbiology and Molecular Genetics identified one of the Chlamydia proteins recognized by T cells during infection and engineered mice where all the T cells in the mice exclusively respond to this Chlamydia protein. These mice are known as T cell receptor transgenic (TCRtg) mice and have none of the T cell diversity found in a normal mouse. Starnbach and his team harvested T cells from the Chlamydia-specific TCRtg mice, labeled them with a dye, and injected them into normal mice. By boosting the number of Chlamydia-specific T cells in the recipient mice, they were able to identify and monitor them as they responded to infection.
"We found that when the recipient mice were infected with Chlamydia, the labeled T cells became activated specifically in the lymph nodes near the reproductive tract, expanded in number in those lymph nodes, and migrated into the mucosa lining the genital tract," Starnbach said. "We also found that the T cells recruited to the genital mucosa secrete gamma interferon as they respond to Chlamydia infection. Gamma interferon secretion has been described as the key molecule T cells use to rid the body of Chlamydia."
The findings show how T cell responses can be studied in reproductive tissues, which is likely to reveal avenues to the development of vaccines against Chlamydia, and possibly other STDs.
"In this report, we identify one candidate protein, Cta1, and show that T cells specific for Cta1 can reduce Chlamydia infection," Starnbach said. "In designing a vaccine, we would want to make sure the vaccine stimulates T cells with characteristics that cause them to home to the genital tract - the site of infection. We also would want them to respond with the same arsenal of protective factors – such as the secretion of gamma interferon that we show occurs using our TCRtg tools."
The goal of vaccines is to stimulate a response that mimics exposure to a pathogen, without the risks of actual infection. When a vaccine successfully accomplishes this, protection against future infection results.
Judith Montminy | EurekAlert!
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences